QS Investors LLC Cuts Position in ICU Medical, Inc. (ICUI)
QS Investors LLC lessened its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 1.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 30,592 shares of the medical instruments supplier’s stock after selling 535 shares during the quarter. QS Investors LLC owned about 0.15% of ICU Medical worth $5,277,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of ICUI. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of ICU Medical by 10.3% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 707 shares of the medical instruments supplier’s stock valued at $122,000 after buying an additional 66 shares during the last quarter. Riverhead Capital Management LLC lifted its holdings in shares of ICU Medical by 99.8% in the 2nd quarter. Riverhead Capital Management LLC now owns 999 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 499 shares during the period. Victory Capital Management Inc. lifted its holdings in shares of ICU Medical by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 1,050 shares of the medical instruments supplier’s stock valued at $181,000 after buying an additional 157 shares during the period. Ameritas Investment Partners Inc. acquired a new position in shares of ICU Medical in the 1st quarter valued at about $194,000. Finally, Parametrica Management Ltd acquired a new position in shares of ICU Medical in the 2nd quarter valued at about $213,000. Institutional investors own 78.13% of the company’s stock.
In other news, CFO Scott E. Lamb sold 23,772 shares of the business’s stock in a transaction that occurred on Tuesday, July 11th. The stock was sold at an average price of $170.02, for a total value of $4,041,715.44. Following the transaction, the chief financial officer now owns 9,050 shares of the company’s stock, valued at $1,538,681. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Chairman Vivek Jain sold 100,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 11th. The stock was sold at an average price of $170.80, for a total value of $17,080,000.00. Following the sale, the chairman now owns 110,925 shares of the company’s stock, valued at approximately $18,945,990. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 213,012 shares of company stock valued at $36,438,659. 15.90% of the stock is owned by company insiders.
ILLEGAL ACTIVITY WARNING: This story was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The legal version of this story can be read at https://www.watchlistnews.com/qs-investors-llc-cuts-position-in-icu-medical-inc-icui/1603176.html.
ICU Medical, Inc. (NASDAQ:ICUI) opened at 185.55 on Monday. The firm has a market capitalization of $3.68 billion, a PE ratio of 74.31 and a beta of 0.35. The company has a 50 day moving average of $173.09 and a 200 day moving average of $164.39. ICU Medical, Inc. has a 1-year low of $124.68 and a 1-year high of $188.85.
ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by ($0.06). The company had revenue of $331.51 million during the quarter, compared to analyst estimates of $318.30 million. ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The business’s revenue was up 242.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.15 EPS. Analysts forecast that ICU Medical, Inc. will post $4.11 EPS for the current year.
ICUI has been the topic of a number of recent research reports. Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $193.00 target price on the stock in a research note on Thursday, July 20th. Gabelli reaffirmed a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. BidaskClub upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Saturday, June 17th. Finally, Sidoti cut ICU Medical from a “buy” rating to a “neutral” rating in a research report on Tuesday, June 20th. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company. ICU Medical currently has a consensus rating of “Hold” and an average price target of $193.00.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.